medigraphic.com
Órgano oficial de la Sociedad Mexicana de Cirugía Dermatológica y Oncológica, AC

2009, Number 1

<< Back Next >>

Dermatología Cosmética, Médica y Quirúrgica 2009; 7 (1)

Acquired progressive lymphangioma

Tschen JA, Martinelli PT, Cohen PR, Chang P, Siekavizza JL, Tschen JA

Language: Spanish
References: 21
Page: 49-53
PDF size: 110.70 Kb.


ABSTRACT

Acquired progressive lymphangioma (APL) is a rare disorder characterized by a brown, red, or violaceous plaque that grows slowly with time. The condition is usually asymptomatic and typically presents in childhood. We present a 14-year-old hispanic female with APL on the lower extremities, abdomen, anterior chest, shoulders, and back. The monoclonal antibody D2-40, a marker of lymphatic endothelium, was used to confirm the diagnosis. We also review the 34 previously reported patients with APL.


REFERENCES

  1. Wilson-Jones E. “Malignant vascular tumours”. Clin Exp Dermatol 1976; 1: 287-312.

  2. Gold SC. “Angioendothelioma (lymphatic type)”. Br J Dermatol 1970; 82: 92-93.

  3. Watanabe M, Kishiyama K, Ohkawara A. “Acquired progressive lymphangioma”. J Am Acad Dermatol 1983; 8: 663-667.

  4. Soohoo L, Mercurio MG, Brody R, Zaim MT. “An acquired vascular lesion in a child: acquired progressive lymphangioma”. Arch Dermatol 1995; 131: 341-345.

  5. Grunwald MH, Amichai B, Avinoach I. Acquired progressive lymphangioma”. J Am Acad Dermatol 1997; 37: 656-657.

  6. Kato H, Kadoya A. “Acquired progressive lymphangioma occurring following femoral arteriography”. Clin Exp Dermatol 1996; 21: 159-162.

  7. Rosso R, Gianelli U, Carnevali L. “Acquired progressive lymphangioma of the skin following radiotherapy for breast carcinoma”. J Cutan Pathol 1995; 22: 164-167.

  8. Meunier L, Barneon G, Meynadier J. “Acquired progressive lymphangioma”. Br J Dermatol 1994; 131: 706-708.

  9. Zhu WY, Penneys NS, Reyes B, Khatib Z, Schachner L. “Acquired progressive lymphangioma”. J Am Acad Dermatol 1991; 24: 813-815.

  10. Hwang LY, Guill CK, Page RN, Hsu S. “Acquired progressive lymphangioma”. J Am Acad Dermatol 2003; 49: S250-S251.

  11. Lewis R, Wallace HJ. “Angio-endothelioma”. Br J Dermatol 1967; 79: 361-362.

  12. Mehregan DR, Mehregan AH, Mehragan DA. “Benign lymphangioendothelioma: report of 2 cases”. J Cutan Pathol 1992; 19: 502-505.

  13. Guillou L, Fletcher C. “Guillou L, Fletcher CD. Benign lymphangioendothelioma (acquired progressive lymphangioma): a lesion not to be confused with well-differentiated angiosarcoma and patch stage Kaposi’s sarcoma”. Am J Surg Path 2000; 24(8): 1047-1057.

  14. Herron GS, Rouse RV, Kosek JC, Smoller BR, Egbert BM. “Benign lymphangioendothelioma”. J Am Acad Dermatol 1994; 31: 362-368.

  15. Tadaki T, Aiba S, Masu S, Tagami H. “Acquired progressive lymphangioma as a flat erythematous patch on the abdominal wall of a child”. Arch Dermatol 1988; 124: 699-701.

  16. Renshaw AA, Rosai J. “Benign atypical vascular lesions of the lip. A study of 12 cases”. Am J Surg Pathol 1993; 17: 557-565.

  17. Wilson Jones E, Winkelmann RK, Zachary CB, Reda AM. “Benign lympahngioendothelioma”. J Am Acad Dermatol 1990; 23: 229-235.

  18. Zachary CB, Jones EW, Spaull J. “Progressive lymphangioma: differential diagnosis and endothelial cell marker studies”. Arch Dermatol 1984; 120: 1617.

  19. Kahn HJ, Bailey D, Marks A. “Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi’s sarcoma and a subset of angiosarcomas”. Mod Pathol 2002; 15: 434-440.

  20. 20.Niakosari F, Kahn HJ, Marks A, From L. “Detection of lymphatic invasion in primary melanoma with monoclonal antibody D2-40: a new selective immunohistochemical marker of lymphatic endothelium”. Arch Dermatol 2005; 141: 440-444.

  21. Wilson-Jones E, Feiwel M. “Malignant angio-endothelioma”. Proc R Soc Med 1963; 56: 299-300.




2020     |     www.medigraphic.com